Leinonen E - Search Results

1

Lack of association between two polymorphisms of brain-derived neurotrophic factor and response to typical neuroleptics.

Anttila S, Illi A, Kampman O, Mattila KM, Lehtimäki T, Leinonen E. Anttila S, et al. Among authors: leinonen e. J Neural Transm (Vienna). 2005 Jul;112(7):885-90. doi: 10.1007/s00702-004-0233-9. Epub 2004 Nov 3. J Neural Transm (Vienna). 2005. PMID: 15526143

2

Early developmental differences between DSM-III-R schizophrenics treated with clozapine and typical neuroleptics.

Mäkikyrö T, Leinonen E, Koponen H, Järvelin MR, Hakko H, Saarnisaari O, Isohanni M. Mäkikyrö T, et al. Among authors: leinonen e. J Psychiatr Res. 1998 Mar-Apr;32(2):105-10. doi: 10.1016/S0022-3956(98)00056-9. J Psychiatr Res. 1998. PMID: 9694006

3

Attitudes towards neuroleptic treatment: reliability and validity of the attitudes towards neuroleptic treatment (ANT) questionnaire.

Kampman O, Lehtinen K, Lassila V, Leinonen E, Poutanen O, Koivisto A. Kampman O, et al. Among authors: leinonen e. Schizophr Res. 2000 Oct 27;45(3):223-34. doi: 10.1016/s0920-9964(99)00204-2. Schizophr Res. 2000. PMID: 11042440

4

A review of the pharmacological and clinical profile of mirtazapine.

Anttila SA, Leinonen EV. Anttila SA, et al. Among authors: leinonen ev. CNS Drug Rev. 2001 Fall;7(3):249-64. doi: 10.1111/j.1527-3458.2001.tb00198.x. CNS Drug Rev. 2001. PMID: 11607047 Free PMC article. Review.

5

Duloxetine Eli Lilly.

Anttila S, Leinonen E. Anttila S, et al. Among authors: leinonen e. Curr Opin Investig Drugs. 2002 Aug;3(8):1217-21. Curr Opin Investig Drugs. 2002. PMID: 12211418 Review.

6

Four-year outcome in non-compliant schizophrenia patients treated with or without home-based ambulatory outpatient care.

Kampman O, Illi A, Poutanen P, Leinonen E. Kampman O, et al. Among authors: leinonen e. Eur Psychiatry. 2003 Feb;18(1):1-5. doi: 10.1016/s0924-9338(02)00006-8. Eur Psychiatry. 2003. PMID: 12648888

7

Interaction between angiotensin-converting enzyme and catechol-O-methyltransferase genotypes in schizophrenics with poor response to conventional neuroleptics.

Illi A, Kampman O, Anttila S, Roivas M, Mattila KM, Lehtimäki T, Leinonen E. Illi A, et al. Among authors: leinonen e. Eur Neuropsychopharmacol. 2003 May;13(3):147-51. doi: 10.1016/s0924-977x(02)00176-1. Eur Neuropsychopharmacol. 2003. PMID: 12729939 Clinical Trial.

8

NOTCH4 gene promoter polymorphism is associated with the age of onset in schizophrenia.

Anttila S, Kampman O, Illi A, Roivas M, Mattila KM, Lassila V, Lehtimäki T, Leinonen E. Anttila S, et al. Among authors: leinonen e. Psychiatr Genet. 2003 Jun;13(2):61-4. doi: 10.1097/01.ypg.0000056681.82896.6b. Psychiatr Genet. 2003. PMID: 12782960

9

Catechol-O-methyltransferase and monoamine oxidase A genotypes and drug response to conventional neuroleptics in schizophrenia.

Illi A, Mattila KM, Kampman O, Anttila S, Roivas M, Lehtimäki T, Leinonen E. Illi A, et al. Among authors: leinonen e. J Clin Psychopharmacol. 2003 Oct;23(5):429-34. doi: 10.1097/01.jcp.0000088916.02635.33. J Clin Psychopharmacol. 2003. PMID: 14520117

10

Dopamine receptor D2 -141C Insertion/Deletion polymorphism in a Finnish population with schizophrenia.

Kampman O, Anttila S, Illi A, Lehtimäki T, Mattila KM, Roivas M, Leinonen E. Kampman O, et al. Among authors: leinonen e. Psychiatry Res. 2003 Nov 1;121(1):89-92. doi: 10.1016/s0165-1781(03)00201-4. Psychiatry Res. 2003. PMID: 14572625

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239 results

Search Page

Filters